GRASS MIX Number 4-S
NDC 0268-8027, AGROSTIS GIGANTEA POLLEN, DACTYLIS GLOMERATA POLLEN, PHLEUM PRATENSE POLLEN and POA PRATENSIS POLLEN, injection, solution, from ALK-Abello, Inc..
- Product NDC
- 0268-8027
- Status
- Listed
- Labeler
- ALK-Abello, Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- STANDARDIZED ALLERGENIC
- Marketing category
- BLA
- Application
- BLA103058
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0268-8027 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- POA PRATENSIS POLLEN25000 [BAU]/mL
- AGROSTIS GIGANTEA POLLEN25000 [BAU]/mL
- DACTYLIS GLOMERATA POLLEN25000 [BAU]/mL
- PHLEUM PRATENSE POLLEN25000 [BAU]/mL
Pharmacologic classes
Allergens [CS]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Non-Standardized Pollen Allergenic Extract [EPC]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Pollen [CS]; Standardized Pollen Allergenic Extract [EPC]; Standardized Pollen Allergenic Extract [EPC]; Standardized Pollen Allergenic Extract [EPC]; Standardized Pollen Allergenic Extract [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0268-8027-50 | 00268802750 | 53 mL in 1 VIAL (0268-8027-50) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 0268-8027 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0268-8027 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0268-8027. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.